Optical Spectroscopy Applied to PAT for In-Line Monitoring in Pharmaceutical Manufacturing

Warman and Gillham address the need for and processes involved in improving in-line monitoring software for pharmaceutical manufacturing.

About Martin Warman
Martin Warman is director of Martin Warman Consultancy Ltd. He has recently stepped down as a professor of practice at the University of Strathclyde, and from being the research director for the Medicine Manufacturing Innovation Centre (MMIC) but continues to work with the MMIC in a consultancy role. He worked previously for seven years at Vertex Pharmaceuticals, developing the Vertex continuous manufacturing (CM) platform, on which the first approved CM products are manufactured. He has over 25 years of experience in the field of process development, having previously led the Global Process Analytical Technology (PAT) Development Team at Pfizer Global Manufacturing. He plays an active role in ASTM E55 as the technical lead on standards for PAT sampling, PAT-enabled control systems, and CM. Warman is also an associate member of Centre for Process Analytics and Control Technology (CPACT).

About Paul Gillham
Paul Gillham is director of innovation at Optimal Industrial Technologies Ltd. in the UK. He has more than a decade of experience in PAT, software, and compliance—especially for quality-by-design (QbD) innovation in pharmaceutical manufacturing.